Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
ID05725590

A Multicenter Randomized Controlled Study of External Pancreatic Duct Stents in Pancreaticoduodenectomy

Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2023-02-13

300

Participants Needed

1

Research Sites

25 weeks

Total Duration

On this page

Sponsors

S

Second Affiliated Hospital, School of Medicine, Zhejiang University

Lead Sponsor

N

Ningbo No. 1 Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

Pancreatic cancer is a serious and often deadly disease, with pancreaticoduodenectomy being the standard treatment for tumors in the pancreatic head and nearby areas. However, this surgery carries a high risk of complications, especially postoperative pancreatic fistula, which can affect 25% to 50% of patients. Researchers are studying whether using external versus internal pancreatic duct stents can lower the risk of these complications, focusing on patients with different levels of risk as determined by the Updated Alternative Fistula Risk Score (ua-FRS). The study compares two types of pancreatic duct stents during pancreaticoduodenectomy: an external stent, which exits through the abdominal wall, and an internal stent, a silicone catheter placed inside the pancreatic duct and jejunum. All surgeries are performed by the same specialized team using laparoscopic or open approaches, with reconstruction using the child's technique. Patients are assigned randomly to receive either the external or internal stent to evaluate the effect on postoperative outcomes. Participants will be monitored for at least one month after surgery to track the occurrence of clinically relevant postoperative pancreatic fistula (CR-POPF) and other complications. Assessments include clinical evaluations and follow-up to measure the primary outcome of CR-POPF incidence. The study aims to clarify the safety and effectiveness of external stents in both high-risk and low-risk patients undergoing pancreaticoduodenectomy, with all procedures and outcomes carefully recorded by the research team.

CONDITIONS

Brief Title

A Multicenter Randomized Controlled Study of External Pancreatic Duct Stents in Pancreaticoduodenectomy

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Pancreatoduodenectomy with pancreaticojejunal mucosa anastomosis performed
  • No combined organic diseases in the heart, lungs, or kidneys
  • No history of chemotherapy, radiotherapy, upper abdominal surgery, or other tumors
  • A pancreatic fistula risk score (ua-FRS) higher than 5%
Not Eligible

You will not qualify if you...

  • Previous history of other tumors or upper abdominal surgery
  • Multiple lesions and distant metastasis
  • Organic diseases of important organs such as heart, lung, and kidney that prevent surgery
  • Age less than 18 years or greater than 75 years
  • Use of other methods to prevent pancreatic fistula, such as fibrin glue sealing, that may affect study accuracy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery and Immediate Post-operative Care

Duration - Hospital stay of variable length after surgery

Participants undergo pancreaticoduodenectomy with either an external or internal pancreatic duct stent placed during surgery to help prevent postoperative pancreatic fistula. Immediate post-operative care is provided after the procedure.

1 surgical procedure with in-hospital care

Post-operative Follow-up

Duration - Up to 1 month after surgery

Participants are monitored for clinically relevant postoperative pancreatic fistula and other complications following surgery.

Approximately 1 to 2 follow-up visits within 1 month

Trial Site Locations

Total: 1 location

1

2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

Hangzhou, China

Actively Recruiting

Loading map...

Research Team

S

Sheng Yan, Doctor

G

Guogang Li, Doctor

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Similar Trials

The Impact of External Pancreatic Drainage During Pancreatic...

Pancreatic Fistula

Actively Recruiting

1 location

Immunoparalysis After Pancreaticoduodenectomy: a Pilot Multi...

Pancreatic Ductal Adenocarcinoma (mPDAC)

Actively Recruiting

4 locations

Indocyanine Green Fluorescence in Evaluation of Post-resecti...

Pancreatic Fistula

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here